Tiragolumab Combo Misses Endpoints in Metastatic Non-Squamous NSCLC Trial
Oncology Nurse Advisor
by Steve Duffy
2w ago
The SKYSCRAPER-06 study compared tiragolumab plus atezolizumab and chemotherapy to pembrolizumab plus chemotherapy in adults with previously untreated, locally advanced unresectable or metastatic nSq NSCLC ..read more
Visit website
NDA Submitted for Niraparib Plus Abiraterone Acetate + Prednisone for Prostate Cancer
Oncology Nurse Advisor
by Steve Duffy
2w ago
The application is supported by data from a phase 3 study evaluating niraparib plus AAP as first-line treatment in patients with mCRPC with or without alterations in HRR associated genes ..read more
Visit website
Jaypirca Approved for Relapsed/Refractory Mantle Cell Lymphoma
Oncology Nurse Advisor
by Diana Ernst, RPh
2w ago
As a noncovalent inhibitor of BTK, pirtobrutinib is able to reestablish BTK inhibition in patients previously treated with covalent BTK inhibitors ..read more
Visit website
Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor
Oncology Nurse Advisor
by Steve Duffy
2w ago
A new dosing regimen for Turalio (pexidartinib) is available for the treatment of adults with symptomatic tenosynovial giant cell tumor ..read more
Visit website
Orserdu Approved for ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
Oncology Nurse Advisor
by Steve Duffy
2w ago
In patients whose tumors had ESR1 mutations, elacestrant reduced the risk of progression or death by 45 ..read more
Visit website
Rolvedon Approved for Chemotherapy-Induced Neutropenia
Oncology Nurse Advisor
by Steve Duffy
2w ago
Rolvedon is a novel, long-acting granulocyte colony-stimulating factor comprised of 2 protein components, an analogue of G-CSF and an Fc antibody fragment ..read more
Visit website
Immunotherapy Combo Reduces Risk of Cancer Recurrence in Early-Stage Liver Cancer
Oncology Nurse Advisor
by Steve Duffy
2w ago
The IMbrave050 study included 662 patients with HCC at high risk for recurrence after surgical resection or ablation with curative intent ..read more
Visit website
Tukysa Combo Approved for RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer
Oncology Nurse Advisor
by Steve Duffy
2w ago
The approval was based on data from the phase 2 MOUNTAINEER trial, which included patients with HER2-positive unresectable or metastatic colorectal cancer ..read more
Visit website
Focus on Psychosocial Adjustment Essential for Young Adults With Hematologic Cancer
Oncology Nurse Advisor
by Stephan Cho
2M ago
Researchers sought to identify factors that contribute to worse psychosocial adjustment in young adults with hematologic cancers ..read more
Visit website
Predicting the Risk of Myeloid Neoplasms After CAR T-Cell Therapy
Oncology Nurse Advisor
by Erin Clancy
3M ago
Researchers have identified factors that are associated with an increased risk of developing myeloid neoplasms after CAR T-cell therapy ..read more
Visit website

Follow Oncology Nurse Advisor on FeedSpot

Continue with Google
Continue with Apple
OR